Found 42 matching trials
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer PHASE2 Research purposes: the research design in the late more than 2 lines TNBC p...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial
Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma PHASE2 This is a phase 2, open-label, single-arm clinical trial evaluating neoadju...
Show More Location
Hospital of Stomatology, Sun Yat-sen University
Learn More & Join Trial
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors PHASE1 The study is being conducted to explore the reasonable dosage and evaluate ...
Show More Location
Hunan Provincial Cancer Hospital
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma PHASE2 The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibit...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer PHASE1 This is a Phase Ib/II clinical study to evaluate the safety, tolerability, ...
Show More Location
Peking University cancer Hospital
Learn More & Join Trial
Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma PHASE2 Advanced gastric cancer (AGC) and gastroesophageal junction (GEJ) adenocarc...
Show More Location
Multiple Locations
Learn More & Join Trial
SNF Platform Study of HR+/ HER2-advanced Breast Cancer PHASE2 The purpose of this study is to establish a prospective, multi-center platf...
Show More Location
Breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free. PHASE3 Open-label, phase III, randomized, stratified (PDL1- vs PDL1+), 3 arms, mul...
Show More Location
Hospital General Universitario de Alicante
Learn More & Join Trial
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors PHASE1 This is a first-in-human, Phase 1/2 study to evaluate LCB84, a TROP2-direct...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial